The answer may be no if you're not making the most of daily patient interactionsSeveral years ago, I was more than 45 minutes late to see a patient whoalso happened to be a good friend. When I came into the exam room he waslivid and said to me, "Neil, would you go to a physician like you?"
Study identifies 11 gene mutations linked to aggressive prostate cancer
October 3rd 2023This is the largest prostate cancer study that examined the exome, according to the researchers, who believe their findings can potentially inform the makeup of panels used for genetic testing in prostate cancer.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
2 Clarke Drive
Cranbury, NJ 08512